BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21898832)

  • 1. Identification and characterization of inhibitors of the aminoglycoside resistance acetyltransferase Eis from Mycobacterium tuberculosis.
    Green KD; Chen W; Garneau-Tsodikova S
    ChemMedChem; 2012 Jan; 7(1):73-7. PubMed ID: 21898832
    [No Abstract]   [Full Text] [Related]  

  • 2. Probing the Robustness of Inhibitors of Tuberculosis Aminoglycoside Resistance Enzyme Eis by Mutagenesis.
    Green KD; Punetha A; Hou C; Garneau-Tsodikova S; Tsodikov OV
    ACS Infect Dis; 2019 Oct; 5(10):1772-1778. PubMed ID: 31433614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent 1,2,4-Triazino[5,6 b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis.
    Ngo HX; Green KD; Gajadeera CS; Willby MJ; Holbrook SYL; Hou C; Garzan A; Mayhoub AS; Posey JE; Tsodikov OV; Garneau-Tsodikova S
    ACS Infect Dis; 2018 Jun; 4(6):1030-1040. PubMed ID: 29601176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from
    Punetha A; Ngo HX; Holbrook SYL; Green KD; Willby MJ; Bonnett SA; Krieger K; Dennis EK; Posey JE; Parish T; Tsodikov OV; Garneau-Tsodikova S
    ACS Chem Biol; 2020 Jun; 15(6):1581-1594. PubMed ID: 32421305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis.
    Willby MJ; Green KD; Gajadeera CS; Hou C; Tsodikov OV; Posey JE; Garneau-Tsodikova S
    ACS Chem Biol; 2016 Jun; 11(6):1639-46. PubMed ID: 27010218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors.
    Garzan A; Willby MJ; Ngo HX; Gajadeera CS; Green KD; Holbrook SY; Hou C; Posey JE; Tsodikov OV; Garneau-Tsodikova S
    ACS Infect Dis; 2017 Apr; 3(4):302-309. PubMed ID: 28192916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redesign of substrate specificity and identification of the aminoglycoside binding residues of Eis from Mycobacterium tuberculosis.
    Jennings BC; Labby KJ; Green KD; Garneau-Tsodikova S
    Biochemistry; 2013 Jul; 52(30):5125-32. PubMed ID: 23837529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB.
    Chen W; Biswas T; Porter VR; Tsodikov OV; Garneau-Tsodikova S
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9804-8. PubMed ID: 21628583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A consensus reverse docking approach for identification of a competitive inhibitor of acetyltransferase enhanced intracellular survival protein from Mycobacterium tuberculosis.
    Santos-Júnior PFDS; Batista VM; Nascimento IJDS; Nunes IC; Silva LR; Costa CACB; Freitas JD; Quintans-Júnior LJ; Araújo-Júnior JX; Freitas MEG; Zhan P; Green KD; Garneau-Tsodikova S; Mendonça-Júnior FJB; Rodrigues-Junior VS; Silva-Júnior EFD
    Bioorg Med Chem; 2024 Jun; 108():117774. PubMed ID: 38833750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and structural analysis of aminoglycoside acetyltransferase Eis from Anabaena variabilis.
    Pricer RE; Houghton JL; Green KD; Mayhoub AS; Garneau-Tsodikova S
    Mol Biosyst; 2012 Oct; 8(12):3305-13. PubMed ID: 23090428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Mechanistic Analysis of Structurally Diverse Inhibitors of Acetyltransferase Eis among FDA-Approved Drugs.
    Pang AH; Green KD; Punetha A; Thamban Chandrika N; Howard KC; Garneau-Tsodikova S; Tsodikov OV
    Biochemistry; 2023 Feb; 62(3):710-721. PubMed ID: 36657084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.
    Labby KJ; Garneau-Tsodikova S
    Future Med Chem; 2013 Jul; 5(11):1285-309. PubMed ID: 23859208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonamide-Based Inhibitors of Aminoglycoside Acetyltransferase Eis Abolish Resistance to Kanamycin in Mycobacterium tuberculosis.
    Garzan A; Willby MJ; Green KD; Gajadeera CS; Hou C; Tsodikov OV; Posey JE; Garneau-Tsodikova S
    J Med Chem; 2016 Dec; 59(23):10619-10628. PubMed ID: 27933949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
    Zaunbrecher MA; Sikes RD; Metchock B; Shinnick TM; Posey JE
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20004-9. PubMed ID: 19906990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA.
    Inoyama D; Awasthi D; Capodagli GC; Tsotetsi K; Sukheja P; Zimmerman M; Li SG; Jadhav R; Russo R; Wang X; Grady C; Richmann T; Shrestha R; Li L; Ahn YM; Ho Liang HP; Mina M; Park S; Perlin DS; Connell N; Dartois V; Alland D; Neiditch MB; Kumar P; Freundlich JS
    Cell Chem Biol; 2020 May; 27(5):560-570.e10. PubMed ID: 32197094
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Borthwick JA; Alemparte C; Wall I; Whitehurst BC; Argyrou A; Burley G; de Dios-Anton P; Guijarro L; Monteiro MC; Ortega F; Suckling CJ; Pichel JC; Cacho M; Young RJ
    J Med Chem; 2020 Mar; 63(5):2557-2576. PubMed ID: 31922409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eis Promoter C14G and C15G Mutations Do Not Confer Kanamycin Resistance in Mycobacterium tuberculosis.
    Pholwat S; Stroup S; Heysell S; Ogarkov O; Zhdanova S; Ramakrishnan G; Houpt E
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7522-7523. PubMed ID: 27736762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in research for resistance mechanisms of aminoglycoside and Cyclic peptide antibiotic to Mycobacterium tuberculosis].
    Song YH; Gao MQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Jul; 35(7):531-3. PubMed ID: 22931808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.